09:00:53 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Canopy Growth Corp
Symbol WEED
Shares Issued 394,315,084
Close 2022-03-30 C$ 9.93
Market Cap C$ 3,915,548,784
Recent Sedar Documents

Canopy Growth appoints Hong as CFO

2022-03-31 10:44 ET - News Release

Mr. David Klein reports

CANOPY GROWTH ANNOUNCES LEADERSHIP APPOINTMENTS AND ADDITION OF STRATEGIC EXECUTIVE RESOURCES

Canopy Growth Corp. has appointed Judy Hong and Jonathan Di Tosto to its executive management team, and has created four new strategic roles within its senior leadership team.

Effective immediately, Ms. Hong has been appointed as the company's chief financial officer. With a proven financial and capital markets background built through more than 20 years of experience at Goldman Sachs & Co., Ms. Hong joined Canopy in 2019 as the vice-president of investor relations. Since arriving, Ms. Hong's deep knowledge of the consumer packaged goods sector has helped shape Canopy's engagement with the financial community, as well as the company's overall commercial strategy.

The company is also pleased to welcome Mr. Di Tosto to the executive management team as the company's new chief operations officer (COO). Mr. Di Tosto assumes the role of COO from Andrew MacCorquodale, who is building upon his five years of dedication to Canopy by transitioning into a strategic advisory role. Mr. Di Tosto joined Canopy in May, 2021, as vice-president, supply chain, where he has focused on optimizing Canopy's global supply chain organization. Prior to Canopy, Mr. Di Tosto spent 16 years with George Weston Ltd., most recently as vice-president, planning and logistics, where he was accountable for the end-to-end supply chain strategy, process and execution throughout Canada and the United States.

"As Canopy evolves, so does our leadership team, and I'm pleased to welcome both Judy and Jonathan, who have demonstrated their capabilities as leaders to drive our business forward," said David Klein, chief executive officer, Canopy. "As we enter our new fiscal year and continue our focus on accelerating growth and advancing on our path to profitability, I feel strongly that we have the right team and strategy to realize our important ambitions for the benefit of our customers, team members and shareholders."

The new executive leaders join the company at a pivotal time, as Canopy enters fiscal year 2023 on Friday, April 1, with a focus on continued discipline and execution against its strategic priorities, including further expanding Canopy's premium flower portfolio and growing overall premium share in Canada, scaling the company's high-impact global brands like BioSteel and Storz & Bickel, and continuing to develop Canopy's U.S. THC (tetrahydrocannabinol) ecosystem pre- and postpermissibility.

To support the continued advancement of Canopy's U.S. strategy, the company has created four new strategic roles within the senior leadership team. These roles will be led by seasoned executives who previously held leadership roles at Constellation Brands and bring with them a breadth of experience, perspective and capabilities to help Canopy achieve its business goals in the U.S. cannabis market in four focused areas: commercial sales, marketing, operations and strategic alliances.

"These roles were developed to leverage Constellation's well-established understanding of the U.S. market, established commercial relationships and extensive operational capabilities," said Mr. Klein. "Accessing Constellation's world-class in-market expertise will allow Canopy to strengthen our competitive positioning as we continue to build a foundation for long-term success in the U.S. market."

The addition of these executive leaders illustrates the meaningful steps forward Canopy is taking to advance its core business objectives. The company looks forward to providing additional insight into its strategy for fiscal year 2023 and beyond during the Q4 and fiscal year 2022 financial earnings report in May.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, it offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible and topical formats, as well as vaporizer devices by Canopy Growth and industry leader Storz & Bickel. Canopy's global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through its award-winning Tweed and Tokyo Smoke banners, the company reaches its adult-use consumers and has built a loyal following by focusing on top-quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets, including Canada, the United States and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.